<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32127526</article-id>
<article-id pub-id-type="pmc">7054353</article-id>
<article-id pub-id-type="publisher-id">750</article-id>
<article-id pub-id-type="doi">10.1038/s41398-020-0750-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Imaging-genetics of sex differences in ASD: distinct effects of <italic>OXTR</italic> variants on brain connectivity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5816-7810</contrib-id>
<name>
<surname>Hernandez</surname>
<given-names>Leanna M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0156-353X</contrib-id>
<name>
<surname>Lawrence</surname>
<given-names>Katherine E.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Padgaonkar</surname>
<given-names>N. Tanya</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inada</surname>
<given-names>Marisa</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoekstra</surname>
<given-names>Jackson N.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lowe</surname>
<given-names>Jennifer K.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eilbott</surname>
<given-names>Jeffrey</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jack</surname>
<given-names>Allison</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aylward</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaab</surname>
<given-names>Nadine</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Horn</surname>
<given-names>John D.</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernier</surname>
<given-names>Raphael A.</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2570-0746</contrib-id>
<name>
<surname>McPartland</surname>
<given-names>James C.</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Webb</surname>
<given-names>Sara J.</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pelphrey</surname>
<given-names>Kevin A.</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Green</surname>
<given-names>Shulamite A.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geschwind</surname>
<given-names>Daniel H.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bookheimer</surname>
<given-names>Susan Y.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dapretto</surname>
<given-names>Mirella</given-names>
</name>
<address>
<email>mirella@g.ucla.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>On behalf of the GENDAAR Consortium</collab>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Ahmanson-Lovelace Brain Mapping Center, </institution><institution>University of California, Los Angeles, </institution></institution-wrap>Los Angeles, CA 90095 USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Department of Psychiatry and Biobehavioral Sciences, </institution><institution>University of California, Los Angeles, </institution></institution-wrap>Los Angeles, CA 90095 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Department of Neurology, David Geffen School of Medicine, </institution><institution>University of California, Los Angeles, </institution></institution-wrap>Los Angeles, CA 90095 USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9510</institution-id><institution-id institution-id-type="GRID">grid.253615.6</institution-id><institution>Autism &amp; Neurodevelopmental Disorders Institute, </institution><institution>The George Washington University, </institution></institution-wrap>Washington, DC USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9026 4165</institution-id><institution-id institution-id-type="GRID">grid.240741.4</institution-id><institution>Center for Integrative Brain Research, </institution><institution>Seattle Children’s Research Institute, </institution></institution-wrap>Seattle, WA USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution>Department of Pediatrics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution>USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Laboratory of Neuro Imaging, Keck School of Medicine of USC, </institution><institution>University of Southern California, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution>Department of Psychiatry and Behavioral Sciences, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution>Department of Pediatrics, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9136 933X</institution-id><institution-id institution-id-type="GRID">grid.27755.32</institution-id><institution>University of Virginia School of Medicine, </institution></institution-wrap>Charlottesville, VA USA </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Department of Human Genetics, </institution><institution>University of California, Los Angeles, </institution></institution-wrap>Los Angeles, CA 90095 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>3</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>10</volume>
<elocation-id>82</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>12</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Autism spectrum disorder (ASD) is more prevalent in males than in females, but the neurobiological mechanisms that give rise to this sex-bias are poorly understood. The female protective hypothesis suggests that the manifestation of ASD in females requires higher cumulative genetic and environmental risk relative to males. Here, we test this hypothesis by assessing the additive impact of several ASD-associated <italic>OXTR</italic> variants on reward network resting-state functional connectivity in males and females with and without ASD, and explore how genotype, sex, and diagnosis relate to heterogeneity in neuroendophenotypes. Females with ASD who carried a greater number of ASD-associated risk alleles in the <italic>OXTR</italic> gene showed greater functional connectivity between the nucleus accumbens (NAcc; hub of the reward network) and subcortical brain areas important for motor learning. Relative to males with ASD, females with ASD and higher <italic>OXTR</italic> risk-allele-dosage showed increased connectivity between the NAcc, subcortical regions, and prefrontal brain areas involved in mentalizing. This increased connectivity between NAcc and prefrontal cortex mirrored the relationship between genetic risk and brain connectivity observed in neurotypical males showing that, under increased <italic>OXTR</italic> genetic risk load, females with ASD and neurotypical males displayed increased connectivity between reward-related brain regions and prefrontal cortex. These results indicate that females with ASD differentially modulate the effects of increased genetic risk on brain connectivity relative to males with ASD, providing new insights into the neurobiological mechanisms through which the female protective effect may manifest.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Autism spectrum disorders</kwd>
<kwd>Clinical genetics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000065</institution-id>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</institution>
</institution-wrap>
</funding-source>
<award-id>F99NS105206</award-id>
<principal-award-recipient>
<name>
<surname>Hernandez</surname>
<given-names>Leanna M.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000025</institution-id>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</institution-wrap>
</funding-source>
<award-id>F31MH110140</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<award-id>F32MH105167</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<award-id>R01MH100028</award-id>
<principal-award-recipient>
<name>
<surname>Lawrence</surname>
<given-names>Katherine E.</given-names>
</name>
<name>
<surname>Eilbott</surname>
<given-names>Jeffrey</given-names>
</name>
<name>
<surname>Jack</surname>
<given-names>Allison</given-names>
</name>
<name>
<surname>Aylward</surname>
<given-names>Elizabeth</given-names>
</name>
<name>
<surname>Gaab</surname>
<given-names>Nadine</given-names>
</name>
<name>
<surname>Van Horn</surname>
<given-names>John D.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>Shulamite A.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>Daniel H.</given-names>
</name>
<name>
<surname>Bookheimer</surname>
<given-names>Susan Y.</given-names>
</name>
<name>
<surname>Dapretto</surname>
<given-names>Mirella</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>ARCS Foundation</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000001</institution-id>
<institution>National Science Foundation (NSF)</institution>
</institution-wrap>
</funding-source>
<award-id>1650604</award-id>
<principal-award-recipient>
<name>
<surname>Padgaonkar</surname>
<given-names>N. Tanya</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Across species, the neuropeptide oxytocin plays a critical role in a wide range of reproductive and complex social processes, including initiation of uterine contractions during childbirth, lactation, pair bonding, and social reward processing<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. The effects of oxytocin are dependent on expression of its receptor throughout the brain and body, and several variants in the oxytocin receptor gene (<italic>OXTR</italic>) have been linked to increased rates of autism spectrum disorder (ASD)<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR6">6</xref></sup>. As social deficits are a core feature of ASD, the oxytocin system has attracted considerable attention as a potential target for pharmacological manipulation in individuals with autism<sup><xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref></sup>. Indeed, in males with ASD, treatment with intranasal oxytocin has been shown to improve social responsivity, seemingly through effects on reward-related subcortical brain areas and frontal brain regions important for social cognition<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>.</p>
<p id="Par3">Given that males are about four times as likely to receive an ASD diagnosis as females<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, it is not surprising that much of the research conducted to date on the neurobiological correlates of oxytocin functioning in individuals with ASD has been in males. However, sex-specific regulation of the oxytocin system has been reported in both animals<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup> and humans<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, suggesting that findings in males may not be generalizable to females. Importantly, animal studies have shown sex-differences in <italic>OXTR</italic> expression in several brain regions important for social functioning and maternal behavior, with females displaying higher expression relative to males<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>, and that genetic variation in the <italic>OXTR</italic> affects the expression of receptors in subcortical brain areas important for social behavior<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. The neurobiological effects of oxytocin suggest that it may have a protective effect by enhancing neural plasticity through induction of long term potentiation<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup> at synapses where the <italic>OXTR</italic> is expressed<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>, and by reducing neuroinflammation through inhibition of microglial activation<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. This evidence for a role of oxytocin in modulating neuroplasticity and inflammation, as well as evidence for brain-based sex-differences in functioning of the oxytocin system, has led some to hypothesize that oxytocin may have a neuroprotective effect against the development of ASD in females<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p>
<p id="Par4">In the genetics literature, theories on the neurogenetic underpinnings of sex differences in ASD have hypothesized a female protective effect (FPE) whereby females require a higher burden of genetic and environmental risk factors to develop ASD<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Evidence for a FPE comes from research showing that females with ASD carry more deleterious copy number and single nucleotide variants relative to males with ASD<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>, and further that genes highly expressed in the male brain also tend to be upregulated in the brains of individuals with ASD<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Together, these studies suggest that the male-bias in ASD may be due to inherent differences in sex-specific neurobiology, which in turn affect the impact that ASD risk variants have on neuroendophenotypes<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. At the neural systems level, sex differences in the capacity of the brain to adapt to genetic and environmental risk factors may mediate the effects of genetic risk for ASD on the brain and ultimately behavior<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>; indeed, genes involved in the regulation of synaptic plasticity have been associated with increased ASD risk<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
<p id="Par5">As multiple SNPs in the <italic>OXTR</italic> have been linked to higher rates of ASD<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR6">6</xref></sup> and altered neural activity to rewards<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, the oxytocin system serves as an ideal model in which to test whether increased genetic risk for ASD affects neural functioning in a dose-dependent manner. In the brain, the oxytocin receptor is expressed in subcortical areas, with enhanced expression in reward-related areas including the NAcc, hypothalamus, and substantia niagra<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>— regions which also show altered function and connectivity in individuals with ASD<sup><xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR44">44</xref></sup>. A recent imaging-genetics study of predominantly male youth with and without ASD showed that in the presence of increased genetic risk for ASD in the <italic>OXTR</italic>, youth with ASD display reduced connectivity between the NAcc and other subcortical brain regions critical for implicit learning and reward processing<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Conversely, typically developing youth with a greater number of ASD-associated variants in the <italic>OXTR</italic> gene display compensatory functional connectivity between the NAcc and prefrontal cortex, which may buffer them from expressing social cognitive deficits indicative of ASD<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. However, researchers have yet to assess potential sex-differences in the dose-dependent relationship between genetic risk for ASD and neuroendophenotypes, and to investigate putative sex-dependent mechanisms of neural plasticity and resilience. Using data from a multisite study focused on gender differences in ASD, here we examined how ASD risk-allele-dosage in the <italic>OXTR</italic> relates to heterogeneity in NAcc network connectivity and, critically, investigate sex differences in the effects of genetic risk on the brain by comparing cohorts of males and females with and without ASD.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Subjects</title>
<p id="Par6">Female participants were high functioning females with ASD (<italic>n</italic> = 50) and neurotypical (NT) females (<italic>n</italic> = 52) between the ages of 8 and 17 (<italic>M</italic> = 13.66, <italic>SD</italic> = 2.67) who were recruited from four sites (Harvard, Seattle Children’s Hospital, University of California, Los Angeles (UCLA), and Yale) as part of the Gender Exploration of Neurogenetics and Development to Advance Autism Research (GENDAAR) multisite consortium. Male participants were high-functioning males with ASD (<italic>n</italic> = 37) and NT males (<italic>n</italic> = 34) between the ages of 8 and 17 (<italic>M</italic> = 13.34, <italic>SD</italic> = 2.05) who were recruited from the Los Angeles area through the UCLA Center for Autism Research and Treatment (CART). Note that male subjects in the current study are the same as described in Hernandez et al.<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>; the sample in that study included several female participants (four ASD, seven NT), which were excluded in the current study where analyses were re-run in NT and ASD male-only subsamples. All previously reported results held (Supplementary Figs. <xref ref-type="media" rid="MOESM1">1</xref>, <xref ref-type="media" rid="MOESM1">2</xref>). The data is publicly available through the NIMH Data Archive (Collection ID 10 and 2021).</p>
<p id="Par7">Participants with a history of claustrophobia, diagnosed neurological disorders, genetic conditions, structural brain abnormalities, or metal implants were excluded from study participation. Study protocols were approved by the Institutional Review Board at each participating site and informed consent and assent to participate in research were obtained from legal guardians and study participants. All participants with ASD had a prior diagnosis for the disorder based on the diagnostic and statistical manual of mental disorders<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, which was confirmed using the Autism Diagnostic Observation Schedule—2nd Edition (ADOS-2)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, Autism Diagnostic Interview-Revised (ADI-R)<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, and best clinical judgment by licensed clinicians at each participating site. Criterion for study inclusion was an IQ above 70 as assessed by the Differential Ability Scales II<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, Wechsler Intelligence Scale for Children-IV<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, or the Wechsler Abbreviated Scale of Intelligence<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Additional behavioral measures included the Social Responsiveness Scale (SRS)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, a measure that provides a quantitative index of autistic traits. The SRS is designed to assess reciprocal social behavior in both NT and ASD individuals ages 4–18 years; questionnaires were completed by parents of study participants. Seventeen ASD females and 18 ASD males reported use of one or more psychotropic medications (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>). A summary of demographic information is presented in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sample descriptives.</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>ASD Females</th><th>ASD Males</th><th>NT Females</th><th>NT Males</th><th>Females ASD vs. NT</th><th>Males ASD vs. NT</th><th>ASD Female vs. Male</th><th>NT Female vs. Male</th></tr></thead><tbody><tr><td>Age</td><td>13.84</td><td>13.50</td><td>13.49</td><td>13.17</td><td>0.59</td><td>0.50</td><td>0.53</td><td>0.60</td></tr><tr><td>Full IQ</td><td>97.91</td><td>105.24</td><td>112.97</td><td>106.26</td><td>0.001<sup>b</sup></td><td>0.72</td><td>0.08</td><td>0.03<sup>a</sup></td></tr><tr><td>Nonverbal IQ</td><td>99.53</td><td>105.65</td><td>110.82</td><td>105.32</td><td>0.009<sup>b</sup></td><td>0.92</td><td>0.12</td><td>0.11</td></tr><tr><td>Verbal IQ</td><td>101.16</td><td>103.73</td><td>111.18</td><td>107.09</td><td>0.018<sup>a</sup></td><td>0.23</td><td>0.50</td><td>0.19</td></tr><tr><td>ADOS social</td><td>7.97</td><td>9.70</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.05<sup>a</sup></td><td>–</td></tr><tr><td>ADOS repetitive behavior</td><td>2.06</td><td>2.29</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.57</td><td>–</td></tr><tr><td>ADOS severity score</td><td>6.13</td><td>7.02</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.10</td><td>–</td></tr><tr><td>ADI social</td><td>19.09</td><td>20.11</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.41</td><td>–</td></tr><tr><td>ADI Communication</td><td>15.77</td><td>16.30</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.64</td><td>–</td></tr><tr><td>ADI repetitive behavior</td><td>6.00</td><td>6.78</td><td>–</td><td>–</td><td>–</td><td>–</td><td>0.21</td><td>–</td></tr><tr><td>Mean relative motion</td><td>0.12</td><td>0.08</td><td>0.09</td><td>0.08</td><td>0.16</td><td>0.27</td><td>0.02<sup>a</sup></td><td>0.10</td></tr><tr><td>Mean volumes scrubbed</td><td>14.97</td><td>2.81</td><td>8.58</td><td>2.97</td><td>0.21</td><td>0.89</td><td>0.003<sup>b</sup></td><td>0.07</td></tr><tr><td>Mean <italic>OXTR</italic> risk variants</td><td>3.44</td><td>3.30</td><td>3.45</td><td>3.12</td><td>0.94</td><td>0.47</td><td>0.58</td><td>0.19</td></tr><tr><td colspan="9">Subjects with ≥1 risk allele</td></tr><tr><td> rs1042778</td><td>28</td><td>30</td><td>27</td><td>23</td><td>0.53</td><td>0.19</td><td>0.47</td><td>0.18</td></tr><tr><td> rs2254298</td><td>6</td><td>7</td><td>8</td><td>9</td><td>0.59</td><td>0.45</td><td>0.99</td><td>0.83</td></tr><tr><td> rs53576</td><td>21</td><td>20</td><td>21</td><td>12</td><td>0.87</td><td>0.11</td><td>0.33</td><td>0.02<sup>a</sup></td></tr><tr><td> rs237887</td><td>28</td><td>27</td><td>25</td><td>29</td><td>0.22</td><td>0.20</td><td>0.14</td><td>0.32</td></tr><tr><td colspan="9">Self-reported ethnicity</td></tr><tr><td> Asian</td><td>2</td><td>2</td><td>3</td><td>3</td><td>0.67</td><td>0.57</td><td>0.88</td><td>0.97</td></tr><tr><td> Black/African American</td><td>0</td><td>2</td><td>3</td><td>6</td><td>0.08</td><td>0.10</td><td>0.18</td><td>0.31</td></tr><tr><td> Other/Mixed</td><td>4</td><td>4</td><td>5</td><td>2</td><td>0.76</td><td>0.46</td><td>0.83</td><td>0.22</td></tr><tr><td> White</td><td>26</td><td>25</td><td>22</td><td>19</td><td>0.18</td><td>0.31</td><td>0.20</td><td>0.37</td></tr></tbody></table><table-wrap-foot><p>Mean values and <italic>p</italic>-values derived from two-tailed independent samples <italic>t</italic>-tests or chi-squared tests. <sup>a</sup><italic>p</italic> &lt; 0.05; <sup>b</sup><italic>p</italic> &lt; 0.01.</p><p><italic>ASD</italic> autism spectrum disorder, <italic>NT</italic> neurotypical, <italic>IQ</italic> intelligence quotient, <italic>ADOS</italic> Autism diagnostic observation schedule, <italic>ADI</italic> Autism Diagnostic interview, <italic>OXTR</italic> oxytocin receptor gene.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Genotyping</title>
<p id="Par8">Genomic DNA from whole blood was obtained from the Rutgers University Cell and Data Repository (RUCDR) or extracted using standard protocols (Gentra Puregene Blood DNA extraction kit; Qiagen). Genotyping for SNPs rs237887 and rs1042778 was performed at Yale University or the UCLA Neuroscience Genomics Core (<ext-link ext-link-type="uri" xlink:href="https://www.semel.ucla.edu/ungc">https://www.semel.ucla.edu/ungc</ext-link>) according to standard manufacturer protocols using the HumanOmni2.5-8 BeadChip microarray (Illumina Inc.) Commercially available TaqMan assays were used to genotype SNPs rs53576 and rs2254298 at the UCLA Genotyping and Sequencing Core (GenoSeq Core; <ext-link ext-link-type="uri" xlink:href="http://genoseq.ucla.edu">http://genoseq.ucla.edu</ext-link>) using a 5′ nuclease assay to discriminate between the two alleles (Taqman SNP Genotyping Assay, Applied Biosystems Inc.). Polymerase chain reactions were performed using 5-μL reaction volumes in 384-well plates with 25 ng of DNA and Taqman genotyping master mix from Applied Biosystems Inc. End point reads of fluorescence levels were obtained with a Roche 480 lightcycler following manufacturer’s protocol. After quality filtering (&lt;5% missing per person/per SNP, &gt;1% minor allele frequency, Hardy-Weinberg equilibrium <italic>p</italic> &gt; 10<sup>−7</sup>), multi-dimensional scaling was performed in PLINK (<ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/plink/">http://pngu.mgh.harvard.edu/purcell/plink/</ext-link>) using the default settings with the HapMap 3 reference panel (<ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov/">http://hapmap.ncbi.nlm.nih.gov/</ext-link>).</p>
</sec>
<sec id="Sec5">
<title>MRI data acquisition</title>
<p id="Par9">Resting-state functional magnetic resonance imaging (rs-fcMRI) data were collected at each of the four GENDAAR participating sites on either a Siemens 3T Trio (12-channel head coil) or a Prisma 3T (20-channel head coil) whole-body scanner. For each subject, a T2*-weighted resting-state functional MRI sequence was acquired (6–8 min, TR = 2000ms, TE = 30 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 3 × 3 mm for females; 6 min, TR = 3000 ms, TE = 28 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 3 × 3 mm for males). For registration purposes, a matched-bandwidth echo-planar scan was also acquired (Siemens Trio: TR = 5000 ms, TE = 34 ms, FOV = 192 mm, 34 slices, slice thickness 4 mm, in-plane voxel size 1.5 × 1.5 mm; Siemens Prisma: identical parameters except for TE = 35 ms, 36 slices).</p>
</sec>
<sec id="Sec6">
<title>fMRI data analysis</title>
<p id="Par10">The rs-fMRI data were analyzed using FSL (FMRIB’s Software Library, <ext-link ext-link-type="uri" xlink:href="http://www.fmri.ox.ac.uk/fsl">www.fmri.ox.ac.uk/fsl</ext-link>)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and AFNI (Analysis of Functional NeuroImages)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Data were processed using the same pipeline described in Hernandez et al.<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> to ensure valid comparisons of results obtained for the male and female groups. Images were skull-stripped using AFNI. Next, FSL’s Motion Correction Linear Registration Tool (MCFLIRT)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> was used to align the functional images with the mean functional volume. Translations in the <italic>x</italic>, <italic>y</italic>, and <italic>z</italic> dimensions were calculated from volume to volume, then averaged to create a measure of mean displacement. Functional data were linearly registered to the matched-bandwidth EPI volume (6 degrees of freedom), followed by registration to the MNI 152 2 mm standard brain (12 degrees of freedom). FSL’s Automatic Segmentation Tool (FAST) was applied to high-resolution scans to create masks for grey matter, white matter, and cerebral spinal fluid for each subject; these variables, as well as the global signal were regressed from the data using FSL’s FEAT. Images were smoothed using a 5 mm FWHM Gaussian kernel. Bandpass filtering was applied to the data (0.1 Hz &gt; <italic>t</italic> &gt; 0.01 Hz).</p>
<p id="Par11">Motion scrubbing was performed, including removal of volumes for which frame-wise displacement exceeded 0.5 mm and DVARS exceeded 0.5%; two volumes preceding and one volume following a scrubbed image were also removed<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Participants with &lt;5 min of data after scrubbing were excluded from final analyses resulting in a final sample of 32 ASD females, 33 NT females, 37 ASD males, and 34 NT males. The mean number of volumes remaining after scrubbing were 176, 179, 117, and 117, for ASD females, NT females, ASD males, and NT males, respectively. There were no differences in the number of volumes remaining between ASD and NT females, or between ASD and NT males. There were significant differences in the mean number of volumes remaining between female and male participants (<italic>p</italic> &lt; 0.01), thus, the number of remaining volumes after scrubbing for each participant was used as a covariate in group-level analyses comparing male and female youth. FSL’s FLIRT was used to register residuals from the motion scrubbed data to the EPI volume (6 degrees of freedom), followed by registration to the MNI 152 2 mm standard brain (12 degrees of freedom). Power calculations were conducted in G*Power 3.1;<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> anticipated effect size estimates were obtained from previously published work assessing the effect of <italic>OXTR</italic> variants on reward network activity<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Sample sizes for males and females with and without ASD in the current study are sufficient to detect significant effects in each group at 80% power and a 0.05 significance level.</p>
<p id="Par12">Statistical analyses were performed using the general linear model in FSL’s FEAT. The NAcc was defined bilaterally using the Harvard Oxford Atlas at a probability threshold of 25%. Average timeseries were extracted from the bilateral NAcc and correlated with every other voxel in the brain to generate functional connectivity maps for each participant. Individual subject-level correlation maps were transformed to <italic>z</italic>-statistic maps using Fisher’s <italic>r</italic> to <italic>z</italic> transform. Single-subject maps were combined in higher-level group analyses in FSL’s FEAT using FLAME 1 + 2, a mixed effects model. Female diagnostic groups (i.e., female ASD vs. NT) did not differ in age; however, as diagnostic groups differed in IQ and the number of participants who underwent MRI at each site (Table <xref ref-type="table" rid="Tab1">1</xref>) these variables were used as covariates in group-level comparisons. Male diagnostic groups (i.e., male ASD vs. NT) did not show any between-group differences in demographic variables; accordingly, comparisons between male diagnostic groups did not include covariates. Results of NAcc whole-brain connectivity analyses are presented at z &gt; 3.1 (<italic>p</italic> &lt; 0.001), corrected for multiple comparisons at <italic>p</italic> &lt; 0.05. Group-level analyses testing the interaction between sex and diagnostic status on NAcc connectivity were controlled for demographic variables on which male and female groups differed including MRI data collection site, IQ, and number of functional volumes remaining after motion scrubbing. Examination of sex differences in positive and negative NAcc connectivity focused on regions showing significant connectivity (<italic>z</italic> &gt; 3.1, cluster-corrected at <italic>p</italic> &lt; 0.05) in any group (NT females, NT males, ASD females, ASD males).</p>
<p id="Par13">To assess the aggregate effect of <italic>OXTR</italic> genetic risk on NAcc connectivity, cumulative genetic risk scores were computed for each participant as the sum of the number of ASD-associated risk alleles across four <italic>OXTR</italic> SNPs: rs53576, rs237887, rs1042778, rs2254298 (Supplementary Table <xref ref-type="media" rid="MOESM1">2</xref>). Mean genetic risk was calculated across NT and ASD groups; subjects’ demeaned genetic risk score was entered as a regressor in higher-level FEAT analyses (FLAME 1 + 2). We previously demonstrated that none of the four SNPs contributed disproportionally to altered NAcc-resting state functional connectivity by iteratively assessing effects of three SNPs on brain connectivity in a leave-one-out fashion; results when assessing 3-SNP models were identical to the final 4-SNP model<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Modulation of NAcc connectivity by aggregate <italic>OXTR</italic> risk was assessed at <italic>z</italic> &gt; 3.1, corrected for multiple comparisons at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="Sec7" sec-type="results">
<title>Results</title>
<p id="Par14">Male results for both whole-brain NAcc connectivity and effects of <italic>OXTR</italic> risk variants mirrored those previously reported in a largely overlapping sample of ASD and NT participants<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Greater numbers of ASD-associated variants in the <italic>OXTR</italic> gene were associated with reduced within-network connectivity in males with ASD, and greater connectivity between the NAcc and prefrontal cortex in NT males (Supplementary Figs. <xref ref-type="media" rid="MOESM1">1</xref>, <xref ref-type="media" rid="MOESM1">2</xref>). Below, we first detail the results for <italic>females</italic> with and without ASD, and then examine the interaction between sex, diagnosis, and genetic risk for ASD in the <italic>OXTR</italic>.</p>
<sec id="Sec8">
<title><italic>OXTR</italic> genetic variation in females</title>
<p id="Par15">In females, the average number of risk alleles in the <italic>OXTR</italic> was 3.45 (<italic>SD</italic> = 1.03, range 2–6); NT females had on average 3.45 <italic>OXTR</italic> risk alleles (<italic>SD</italic> = 1.03), ASD females had on average 3.44 <italic>OXTR</italic> risk alleles (<italic>SD</italic> = 1.05; Table <xref ref-type="table" rid="Tab1">1</xref>). An independent samples t-test indicated that, as expected, there was not a significant difference in the average number of <italic>OXTR</italic> risk alleles in NT and ASD females. As previously reported in ASD males<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, inheriting greater numbers of <italic>OXTR</italic> risk alleles was associated with higher calibrated severity scores on the ADOS in females with ASD (<italic>r</italic> = 0.29, one-tailed <italic>p</italic> = 0.05). There were no differences between males and females with and without ASD in the cumulative number of inherited <italic>OXTR</italic> risk-alleles (Table <xref ref-type="table" rid="Tab1">1</xref>), nor any relationships between IQ or medication status and the number of ASD-associated <italic>OXTR</italic> risk alleles.</p>
</sec>
<sec id="Sec9">
<title>Female NAcc whole-brain connectivity</title>
<p id="Par16">The NAcc showed significant connectivity with other key reward-related brain regions in both NT females and females with ASD (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Both groups showed positive connectivity between the NAcc and frontal pole, superior frontal gyrus, frontal medial and orbital cortex, paracingulate and cingulate cortex, caudate, and putamen; connectivity between NAcc and amygdala was observed in NT females only. Negative (anticorrelated) connectivity was observed between the NAcc and occipital cortex (lingual and fusiform gyri). Females with ASD displayed additional negative connectivity between the NAcc and sensorimotor brain regions (bilateral middle frontal gyrus and thalamus, left precentral gyrus, right pallidum and insula) and areas involved in auditory/language processing (i.e., middle temporal gyrus, angular gyrus, parietal operculum). These results lend support to findings previously reported in NT and ASD males, who showed positive connectivity between the NAcc and frontal cortex, anterior cingulate, bilateral caudate and putamen (with NT males having additional NAcc-precuneus positive connectivity), and negative connectivity to thalamus, occipital, and parietal cortex (Supplementary Figs. <xref ref-type="media" rid="MOESM1">1</xref>, <xref ref-type="media" rid="MOESM1">2</xref>)<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. There were no significant differences between NT females and ASD females in NAcc whole-brain positive or negative connectivity.<fig id="Fig1"><label>Fig. 1</label><caption><title>Nucleus accumbens (NAcc) whole-brain connectivity in females with and without ASD.</title><p>Red/yellow indicate positive connectivity with the seed; blue/cyan indicate negative connectivity with the NAcc seed. Maps are shown at <italic>z</italic> &gt; 3.1, corrected for multiple comparisons at <italic>p</italic> &lt; 0.05. NT neurotypical; ASD autism spectrum disorder.</p></caption><graphic id="d29e1823" xlink:href="41398_2020_750_Fig1_HTML"></graphic></fig></p>
<p id="Par17">Next, we compared whole-brain NAcc connectivity between males and females with and without ASD. Sex differences were observed in ASD youth; relative to ASD males, ASD females showed stronger negative connectivity between the NAcc and right lingual gyrus (MNI coordinates: 14, −64, −4; 105 voxels; max <italic>z</italic> = 4.33). No sex differences were observed when comparing NT males and females.</p>
</sec>
<sec id="Sec10">
<title>Cumulative genetic risk: effects on NAcc connectivity in females</title>
<p id="Par18">In females with ASD, greater numbers of ASD-associated variants in the <italic>OXTR</italic> gene were associated with stronger connectivity between the NAcc and subcortical brain regions involved in implicit learning and sensory processing including the dorsal striatum (caudate, putamen) and thalamus, as well as weaker connectivity with visual cortex (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>; Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>). We conducted exploratory analyses whereby parameter estimates of connectivity were extracted from these clusters and correlated with scores on the two ADOS subscales, as well as the Social Cognition subscale of the SRS. A Spearman rank-order correlation indicated that increased NAcc-subcortical connectivity in ASD females was related to higher RRB scores on the ADOS (<italic>r</italic><sub><italic>s</italic></sub> = 0.42, <italic>p</italic> = 0.02; Fig. <xref ref-type="fig" rid="Fig2">2b</xref>); however, this finding did not survive correction for the number of tests performed (<italic>n</italic> = 6). Higher RRB scores in females with ASD also positively correlated with increased <italic>OXTR</italic> genetic risk (<italic>r</italic><sub><italic>s</italic></sub> = 0.46, <italic>p</italic> = 0.01); however, NAcc-subcortical connectivity did not mediate the relationship between genetic risk and RRB.<fig id="Fig2"><label>Fig. 2</label><caption><title>Effects of <italic>OXTR</italic> genetic risk on connectivity of the NAcc in females with and without ASD.</title><p><bold>a</bold> Brain regions showing greater connectivity with the NAcc as a function of increased <italic>OXTR</italic> genetic risk are shown in red/yellow. Areas showing reduced functional connectivity with the NAcc as a function of increased <italic>OXTR</italic> genetic risk are shown in blue/cyan. <bold>b</bold> In females with ASD, greater NAcc-Subcortical connectivity is associated with higher scores on the restricted and repetitive behaviors (RRB) scale of the Autism Diagnostic Observation Scale (ADOS-2)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. <bold>c</bold> Areas in which diagnostic group differences were observed in the relationship between <italic>OXTR</italic> risk-allele dosage and NAcc functional connectivity. Graphs are for illustrative purposes and show the relationship between NAcc connectivity and number of <italic>OXTR</italic> risk alleles for each participant. Maps are shown at <italic>z</italic> &gt; 3.1, corrected for multiple comparisons at <italic>p</italic> &lt; 0.05. NT neurotypical; ASD autism spectrum disorder.</p></caption><graphic id="d29e1916" xlink:href="41398_2020_750_Fig2_HTML"></graphic></fig></p>
<p id="Par19">In contrast, in NT females, increased genetic risk for ASD in the <italic>OXTR</italic> was associated with increased connectivity between the NAcc and frontal brain areas implicated in social cognition/mentalizing (i.e., frontal medial cortex, frontal pole), as well as sensory brain regions (pre/postcentral gyrus, occipital pole). As <italic>OXTR</italic> risk-allele dosage increased, NT females also showed reduced functional connectivity between the NAcc, anterior cingulate gyrus, paracingulate, superior frontal gyrus, and frontal pole (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>; Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>).</p>
<p id="Par20">Between-group comparisons revealed that aggregate <italic>OXTR</italic> risk differentially modulated NAcc connectivity in NT and ASD females in sensory brain regions (bilateral occipital cortex, postcentral gyrus, thalamus), as well as a region in the frontal pole implicated in working memory (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>; Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>). These between-group differences held in a subsample of NT and ASD females matched for IQ (Supplementary Table <xref ref-type="media" rid="MOESM1">4</xref>). To confirm that results were not biased by ancestry, the first two components from multidimensional scaling of genome-wide data were controlled for in a correlation analysis between cumulative risk-allele dosage and parameter estimates extracted from brain regions modulated by <italic>OXTR</italic> risk at the whole-brain level; results in both NT and ASD females remained significant.</p>
</sec>
<sec id="Sec11">
<title>Cumulative genetic risk: sex-specific effects on NAcc connectivity</title>
<p id="Par21">A significant <italic>OXTR</italic> risk-allele dosage by sex by diagnostic group ANCOVA indicated that the effects of <italic>OXTR</italic> in NT males vs. females differed from those observed in ASD males vs. females (Supplementary Fig. <xref ref-type="media" rid="MOESM1">3</xref>). To qualify these findings, simple two-way interactions were tested.</p>
<p id="Par22">Sex significantly modulated the relationship between <italic>OXTR</italic> genetic risk and NAcc connectivity in the ASD group only. Relative to their male counterparts, as genetic risk for ASD increased, females with ASD showed significantly greater connectivity between the NAcc and regions of the mesolimbic reward system, including the caudate, pallidum, and putamen, as well as bilateral thalamus, right prefrontal cortex, and left medial prefrontal cortex (Fig. <xref ref-type="fig" rid="Fig3">3</xref>, Supplementary Table <xref ref-type="media" rid="MOESM1">5</xref>). This region of the left prefrontal cortex that showed greater connectivity with the NAcc in ASD females with high genetic risk (compared to ASD males with high risk) is the same region where NT males show stronger connectivity (compared to ASD males with high risk) as a function of increasing <italic>OXTR</italic> aggregate risk (Supplementary Fig. <xref ref-type="media" rid="MOESM1">2</xref>)<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Furthermore, previous work in NT males has shown that increased NAcc-left prefrontal connectivity is associated with better social cognition as measured by the SRS<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. We thus had an a priori hypothesis that NAcc-left prefrontal connectivity would be related to scores on the SRS social cognition subscale. Indeed, in females with ASD, extracting parameter estimates indexing NAcc-left prefrontal connectivity showed that stronger reward-frontal cortex connectivity was related to better social cognition as measured by the SRS (<italic>r</italic> = −0.43, <italic>p</italic> = 0.02; Fig. <xref ref-type="fig" rid="Fig3">3</xref>). While <italic>OXTR</italic> risk allele-dosage was negatively correlated with SRS scores in females with ASD (<italic>r</italic><sub><italic>s</italic></sub> = −0.4, <italic>p</italic> &lt; 0.05), NAcc-left prefrontal connectivity did not mediate this relationship. Additional exploratory brain-behavior correlations with ADOS subscales and the social cognition subscale of the SRS were examined for clusters showing a sex-specific effect of <italic>OXTR</italic> risk-allele dosage (i.e., right prefrontal cortex and subcortical brain regions shown in Fig. <xref ref-type="fig" rid="Fig3">3</xref>); results were not significant.<fig id="Fig3"><label>Fig. 3</label><caption><title>Distinct effects of <italic>OXTR</italic> variants on brain connectivity in males and females with autism.</title><p>Top: Brain areas showing between-group differences as a function of sex and aggregate <italic>OXTR</italic> risk (z &gt; 3.1, <italic>p</italic> &lt; 0.05). Bottom, right: In ASD females, increased connectivity between the NAcc and left frontal pole is associated with lower social cognition <italic>T-</italic>scores on the SRS (indicative of less severe social-cognitive symptomatology).</p></caption><graphic id="d29e2038" xlink:href="41398_2020_750_Fig3_HTML"></graphic></fig></p>
<p id="Par23">Additional analyses were conducted to test the extent to which gene-brain-behavior patterns observed in ASD females and NT males were indeed similar. First, at the whole-brain level, aggregate <italic>OXTR</italic> risk differentially modulated NAcc connectivity in NT males vs. ASD females in subcortical but not in prefrontal brain regions (Supplementary Fig. <xref ref-type="media" rid="MOESM1">4</xref>). Second, parameter estimates were extracted from the left prefrontal brain areas where ASD females and NT males showed greater connectivity with the NAcc as a function of <italic>OXTR</italic> genetic risk relative to ASD males (i.e., ASD female &gt; ASD male (Fig. <xref ref-type="fig" rid="Fig3">3</xref>) and NT male &gt; ASD male (Supplementary Fig. <xref ref-type="media" rid="MOESM1">2</xref>)); a two-tailed <italic>t</italic>-test using these connectivity indices revealed no significant differences between ASD females and NT males (<italic>p</italic> = 0.26), indicating that connectivity between the NAcc and the left prefrontal cortex did not vary significantly between the two groups. Third, an analysis of covariance (ANCOVA), controlling for the same variables used in our original bottom-up between-group analyses, was used to test for homogeneity of regression slopes (i.e., the slope of the relationship between <italic>OXTR</italic> risk-allele dosage and NAcc-left prefrontal cortex connectivity) between ASD females and NT males; the Group × <italic>OXTR</italic> comparison was not significant (<italic>β</italic> = −0.06, SE = 0.04, <italic>t</italic> = −1.55, <italic>p</italic> = 0.13), indicating no significant differences in slopes between ASD females and NT males.</p>
</sec>
</sec>
<sec id="Sec12" sec-type="discussion">
<title>Discussion</title>
<p id="Par24">Here, we report that common variants in the <italic>OXTR</italic> modulate reward network functional connectivity in both a sex- and diagnosis-dependent manner. Directly comparing males and females with ASD, we found sex-specific associations between <italic>OXTR</italic> variants and brain circuitry such that in the presence of increased genetic risk, females showed greater connectivity between the reward network and prefrontal brain regions important for social cognition and inhibitory control, whereas males showed the opposite pattern. Further, in females with ASD, greater NAcc connectivity with left prefrontal regions was also associated with better functioning on the social cognition subscale of the SRS. Remarkably, these gene-brain-behavior results directly mirror our previously reported findings in NT males, who showed the same pattern whereby NAcc-left prefrontal connectivity increased as a function of increased <italic>OXTR</italic> risk-allele-dosage and was related to better social cognition scores on the SRS<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. These findings suggest that the relationship between <italic>OXTR</italic> genetic risk and brain connectivity in females with ASD, rather than being more similar to ASD males, are more akin to neurotypical males both in terms of reward network-frontal connectivity and brain-behavior relationships. These findings are in agreement with a female protective model of ASD susceptibility in which ASD risk variants (such as those in the <italic>OXTR</italic>) interact with other genes that are expressed in a sex-differential and regionally-specific manner throughout the brain, resulting in the manifestation of sex-specific neuroendophenotypes in individuals with ASD. Gene expression analyses in post-mortem human brain samples have shown that individuals with ASD (compared to neurotypical individuals) and males (compared to females) show downregulation of genes with neural and synaptic functions, as well as upregulation of genes involved in neuroimmune and inflammatory processes<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. Thus, male-typical gene expression profiles may create a background on which ASD-risk genes are likely to have more penetrant/deleterious effects whereas female gene expression profiles may act to buffer the effects of ASD-risk variants on neural circuitry<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Our data support this theory, as we found that cumulative genetic risk for ASD in the <italic>OXTR</italic> has more penetrant effects on connectivity within the reward network in males with ASD compared to NT males<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, and that females with ASD may be in part buffered from the neurobehavioral effects of high <italic>OXTR</italic> genetic risk through formation of compensatory NAcc-prefrontal connectivity. Interestingly, behavioral research suggests that high functioning females with ASD show greater social motivation compared to their male counterparts<sup><xref ref-type="bibr" rid="CR59">59</xref>–<xref ref-type="bibr" rid="CR61">61</xref></sup>, a finding which has been attributed to the ability of females with higher IQ to mask their social-communicative deficits<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. Our findings of increased connectivity between brain regions involved in reward processing and prefrontal brain areas important for metalizing in high functioning females with ASD may provide a neurobiological mechanism supporting this behavioral process.</p>
<p id="Par25">A second feature of ASD females that distinguished them from both ASD males and NT females was that higher <italic>OXTR</italic> risk was related to greater connectivity between the NAcc and subcortical brain regions, a pattern not observed in any other group. Subcortical brain areas in the striatum are known to play a critical role in implicit learning of motor repertoires through cortico-basal ganglia feedback circuits<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>, and indeed this increased NAcc-subcortical connectivity was associated with higher restricted interests and repetitive behavior (RRB) scores on the ADOS in females with ASD. Notably, a sex-bias in expression of repetitive behaviors has been documented in individuals with ASD whereby males generally display more repetitive behaviors and restricted interests relative to females<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. Our imaging-genetics results in ASD females suggest that increased genetic risk in the <italic>OXTR</italic>, as well as associated up-regulation of connectivity between the reward network and subcortical brain regions, may put ASD females at a greater likelihood of expressing RRBs. Although females in our study did not display more severe RRB than males with ASD, we also did not see the typical pattern whereby males with ASD show higher RRB relative to females.</p>
<p id="Par26">That the <italic>OXTR</italic> risk variants investigated in this study would affect frontal and subcortical brain regions in a sex-specific manner are in line with findings from studies using intranasal oxytocin to alter neural activity. In adult neurotypical females, administration of intranasal oxytocin increases connectivity between subcortical brain regions involved in reward and social-emotional processing, and, importantly the effects of oxytocin are greatest in women with higher autistic traits<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Sex differences in the effects of intranasal oxytocin have been documented in neurotypical adults such that oxytocin increases brain activity in the caudate and putamen in men, while decreasing activity in these brain regions in women<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Furthermore, these sex-dependent effects of oxytocin on the brain interact with genetic variants in the <italic>OXTR</italic>. For instance, for the rs53576 SNP on which the A allele has been associated with increased rates of ASD diagnosis, male GG homozygotes (i.e., the non-risk group) show greater caudate activity during a game eliciting social cooperation under oxytocin vs. placebo, while female GG carriers have greater caudate activity in the placebo condition<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. Similarly, for the rs1042778 SNP for which the G allele confers ASD-risk, male TT homozygotes (i.e., the non-risk group) display greater increases in amygdala activity in response to angry faces compared to risk-allele carriers, while no significant difference is observed between female risk and non-risk groups<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. How these results may translate to males and females with ASD and how the modulatory effects of oxytocin may be affected by cumulative genetic risk for ASD in the <italic>OXTR</italic> have yet to be empirically determined. Taken together with previous data, our findings suggest that in addition to investigating the effect of sex on oxytocin treatment outcomes, it is critical that future work also consider sex x diagnosis interactions, as ASD males and females are likely to show different neural responses, at baseline and in response to treatment, from their NT male and female counterparts. Notably, recent research suggests that the effects of oxytocin on neural activity may be modulated not only by sex, but also by age<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, pointing to the need to study the effects of pharmacological treatments in the context of sex-specific neurodevelopmental trajectories.</p>
<p id="Par27">In NT females, greater genetic risk for ASD in the <italic>OXTR</italic> was related to reduced functional connectivity between the NAcc and anterior cingulate (ACC), and increased connectivity with medial orbital frontal cortex (OFC). Both the ACC and OFC are components of the limbic fronto-striatal circuit, which plays a role in reward processing and goal directed planning based on distant outcomes<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Neuroanatomically, when a rewarding stimulus is given (i.e., a smiling face, money, etc.), dopaminergic projections from the midbrain encode reward prediction error<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> and signal to the ventral striatum and frontal cortex, which encode the subjective reward value of the stimulus<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. Thus, the ventral striatum and frontal cortex form a feedback loop that is critical for implicit learning of the relationship between reward prediction and likely outcomes. Our findings in NT females suggest that variability in <italic>OXTR</italic> genotypes impact the relative balance of connectivity between nodes of the fronto-striatal loop in NT females, possibly affecting signaling from the frontal lobe back to subcortical brain regions to impact decision making based on previous reward. Notably, there are sex- and age-dependent differences in structural connectivity between the NAcc and OFC in neurotypical individuals with males showing earlier peak in structural connectivity between these two regions relative to females<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. The developmental trajectory of accumbo-frontal connectivity remains to be explored in males and females with ASD and is an important future direction.</p>
<p id="Par28">In sum, this study examined resting-state functional connectivity of the nucleus accumbens in females with and without ASD to investigate how ASD risk-allele dosage in the <italic>OXTR</italic> relates to between-subject heterogeneity in network connectivity. Critically, we investigated sex differences in the effects of genetic risk on the brain by comparing cohorts of males and females with ASD. Taken together, our results confirm previous evidence that <italic>OXTR</italic> risk variants are indeed associated with distinct neuroendophenotypes in both NT and ASD individuals. Our findings show that the specific brain regions affected and the direction of the observed effect varies as a function of both sex and ASD-diagnostic status. These findings have important implications for treatment studies investigating the effects of intranasal oxytocin on brain activity as they suggest that males and females may have different responses to pharmacological treatment depending on their genetic background and diagnostic status. More broadly, these findings underscore the importance of including females in studies investigating the neural basis of ASD, which in addition to providing insights into the etiology of ASD, can inform our understanding of how variability at the genetic, neural, and behavioral level gives rise to sex differences in rates of ASD diagnosis, and ultimately inform personalized approaches to the treatment of ASD.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec13">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2020_750_MOESM1_ESM.docx"><caption><p>Supplemental Material</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary Information</bold> accompanies this paper at (10.1038/s41398-020-0750-9).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by the National Institute of Neurological Disorders and Stroke (award number F99NS105206 to L.M.H.), the National Institute of Mental Health (award numbers R01MH100028 to K.A.P., F31MH110140 to K.E.L., and F32MH105167 to S.A.G.), the National Science Foundation (Graduate Research Fellowship award number 1650604 to N.T.P.), and the ARCS Foundation. We are also grateful for generous support from the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, Capital Group Companies Charitable Foundation, William M. and Linda R. Dietel Philanthropic Fund, and Northstar Fund. Research reported in this publication was also partially supported by the National Center for Research Resources and by the Office of the Director of the National Institutes of Health under award numbers C06RR012169, C06RR015431, and S10OD011939. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.</p>
</ack>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par29">The authors declare that they have no conflict of interest.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimpl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fahrenholz</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The oxytocin receptor system: structure, function, and regulation</article-title>
<source/>Physiol. Rev.
          <year>2001</year>
<volume>81</volume>
<fpage>629</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.2001.81.2.629</pub-id>
<pub-id pub-id-type="pmid">11274341</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>ZV</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2017</year>
<volume>76</volume>
<fpage>87</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.034</pub-id>
<pub-id pub-id-type="pmid">28434591</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yrigollen</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genes controlling affiliative behavior as candidate genes for autism</article-title>
<source/>Biol. Psychiatry
          <year>2008</year>
<volume>63</volume>
<fpage>911</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.11.015</pub-id>
<pub-id pub-id-type="pmid">18207134</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wermter</surname>
<given-names>A-K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for the involvement of genetic variation in the <italic>oxytocin receptor</italic> gene (<italic>OXTR</italic>) in the etiology of autistic disorders on high-functioning level</article-title>
<source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
          <year>2010</year>
<volume>153B</volume>
<fpage>629</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.31032</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>DB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder</article-title>
<source/>J. Neurodev. Disord.
          <year>2011</year>
<volume>3</volume>
<fpage>101</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-010-9071-2</pub-id>
<pub-id pub-id-type="pmid">21484202</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LoParo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>ID</given-names>
</name>
</person-group>
<article-title>The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</article-title>
<source/>Mol. Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>640</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.77</pub-id>
<pub-id pub-id-type="pmid">25092245</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosaka</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e872</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.152</pub-id>
<pub-id pub-id-type="pmid">27552585</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatawara</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Einfeld</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Hickie</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Davenport</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Guastella</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1225</fpage>
<lpage>1231</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.162</pub-id>
<pub-id pub-id-type="pmid">26503762</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Andari</surname>
<given-names>Elissar</given-names>
</name>
<name>
<surname>Hurlemann</surname>
<given-names>Rene</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>Larry J.</given-names>
</name>
</person-group>
<article-title>A Precision Medicine Approach to Oxytocin Trials</article-title>
<source/>Behavioral Pharmacology of Neuropeptides: Oxytocin
          <year>2017</year>
<publisher-loc>Cham</publisher-loc>
<publisher-name>Springer International Publishing</publisher-name>
<fpage>559</fpage>
<lpage>590</lpage>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin enhances brain function in children with autism</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>20953</fpage>
<lpage>20958</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1312857110</pub-id>
<pub-id pub-id-type="pmid">24297883</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity</article-title>
<source/>JAMA Psychiatry
          <year>2014</year>
<volume>71</volume>
<fpage>166</fpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.3181</pub-id>
<pub-id pub-id-type="pmid">24352377</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menard</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social stress induces neurovascular pathology promoting depression</article-title>
<source/>Nat. Neurosci.
          <year>2017</year>
<volume>20</volume>
<fpage>1752</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-017-0010-3</pub-id>
<pub-id pub-id-type="pmid">29184215</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin’s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial</article-title>
<source/>Mol. Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>447</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.74</pub-id>
<pub-id pub-id-type="pmid">25070538</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism</article-title>
<source/>Brain
          <year>2015</year>
<volume>138</volume>
<fpage>3400</fpage>
<lpage>3412</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awv249</pub-id>
<pub-id pub-id-type="pmid">26336909</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>35054</fpage>
<pub-id pub-id-type="doi">10.1038/srep35054</pub-id>
<pub-id pub-id-type="pmid">27845765</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greene</surname>
<given-names>RK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder</article-title>
<source/>J. Neurodev. Disord.
          <year>2018</year>
<volume>10</volume>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/s11689-018-9228-y</pub-id>
<pub-id pub-id-type="pmid">29587625</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baio</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, United States, 2014</article-title>
<source/>Mmwr. Surveill. Summ.
          <year>2018</year>
<volume>67</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumais</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Veenema</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior</article-title>
<source/>Front. Neuroendocrinol.
          <year>2016</year>
<volume>40</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25951955</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Cushing</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ottinger</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Sex and species differences in plasma oxytocin using an enzyme immunoassay</article-title>
<source/>Can. J. Zool.
          <year>2004</year>
<volume>82</volume>
<fpage>1194</fpage>
<lpage>1200</lpage>
<pub-id pub-id-type="doi">10.1139/z04-098</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebner</surname>
<given-names>NC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin’s effect on resting-state functional connectivity varies by age and sex</article-title>
<source/>Psychoneuroendocrinology
          <year>2016</year>
<volume>69</volume>
<fpage>50</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.03.013</pub-id>
<pub-id pub-id-type="pmid">27032063</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitre</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A distributed network for social cognition enriched for oxytocin receptors</article-title>
<source/>J. Neurosci.
          <year>2016</year>
<volume>36</volume>
<fpage>2517</fpage>
<lpage>2535</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2409-15.2016</pub-id>
<pub-id pub-id-type="pmid">26911697</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitre</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex-specific differences in oxytocin receptor expression and function for parental behavior</article-title>
<source/>Gend. Genome
          <year>2017</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1089/gg.2017.0017</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Walum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Eyrich</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Variation in the Oxytocin Receptor Gene Predicts Brain Region-Specific Expression and Social Attachment</article-title>
<source/>Biol. Psychiatry
          <year>2016</year>
<volume>80</volume>
<fpage>160</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.12.008</pub-id>
<pub-id pub-id-type="pmid">26893121</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubrovsky</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gijsbers</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tatarinov</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Oxytocin induces long-term depression on the rat dentate gyrus: possible ATPase and ectoprotein kinase mediation</article-title>
<source/>Brain Res. Bull.
          <year>2002</year>
<volume>58</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/S0361-9230(01)00748-1</pub-id>
<pub-id pub-id-type="pmid">12127011</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gur</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tendler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Long-term social recognition memory is mediated by oxytocin-dependent synaptic plasticity in the medial amygdala</article-title>
<source/>Biol. Psychiatry
          <year>2014</year>
<volume>76</volume>
<fpage>377</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.03.022</pub-id>
<pub-id pub-id-type="pmid">24787950</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomizawa</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade</article-title>
<source/>Nat. Neurosci.
          <year>2003</year>
<volume>6</volume>
<fpage>384</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1038/nn1023</pub-id>
<pub-id pub-id-type="pmid">12598900</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice</article-title>
<source/>J. Neuroinflammation
          <year>2016</year>
<volume>13</volume>
<fpage>77</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-016-0541-7</pub-id>
<pub-id pub-id-type="pmid">27075756</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dölen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Darvishzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1038/nature12518</pub-id>
<pub-id pub-id-type="pmid">24025838</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mairesse</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia</article-title>
<source/>Glia
          <year>2019</year>
<volume>67</volume>
<fpage>345</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1002/glia.23546</pub-id>
<pub-id pub-id-type="pmid">30506969</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?</article-title>
<source/>Behav. Brain Res.
          <year>2007</year>
<volume>176</volume>
<fpage>170</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2006.08.025</pub-id>
<pub-id pub-id-type="pmid">17000015</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anckarsäter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Happé</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ronald</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Examining and interpreting the female protective effect against autistic behavior</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>5258</fpage>
<lpage>5262</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1211070110</pub-id>
<pub-id pub-id-type="pmid">23431162</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple recurrent de novo cnvs, including duplications of the 7q11.23 williams syndrome region, are strongly associated with autism</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>863</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.002</pub-id>
<pub-id pub-id-type="pmid">21658581</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquemont</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A higher mutational burden in females supports a “Female Protective Model” in neurodevelopmental disorders</article-title>
<source/>Am. J. Hum. Genet.
          <year>2014</year>
<volume>94</volume>
<fpage>415</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.02.001</pub-id>
<pub-id pub-id-type="pmid">24581740</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werling</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Parikshak</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders</article-title>
<source/>Nat. Commun.
          <year>2016</year>
<volume>7</volume>
<fpage>10717</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10717</pub-id>
<pub-id pub-id-type="pmid">26892004</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werling</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>The role of sex-differential biology in risk for autism spectrum disorder</article-title>
<source/>Biol. Sex. Differ.
          <year>2016</year>
<volume>7</volume>
<fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/s13293-016-0112-8</pub-id>
<pub-id pub-id-type="pmid">27891212</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mottron</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>33</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0024-1</pub-id>
<pub-id pub-id-type="pmid">26052415</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2015</year>
<volume>16</volume>
<fpage>551</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3992</pub-id>
<pub-id pub-id-type="pmid">26289574</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damiano</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between the oxytocin receptor (OXTR) gene and mesolimbic responses to rewards</article-title>
<source/>Mol. Autism
          <year>2014</year>
<volume>5</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-7</pub-id>
<pub-id pub-id-type="pmid">24485285</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bethlehem</surname>
<given-names>RAI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1099</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2017.72</pub-id>
<pub-id pub-id-type="pmid">28418398</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<mixed-citation publication-type="other">Supekar, K. et al. Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism. <italic>Brain</italic>. 10.1093/brain/awy191 (2018).</mixed-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott-Van Zeeland</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Dapretto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghahremani</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Poldrack</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bookheimer</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Reward processing in autism</article-title>
<source/>Autism Res.
          <year>2010</year>
<volume>3</volume>
<fpage>n/a</fpage>
<lpage>n/a</lpage>
<pub-id pub-id-type="doi">10.1002/aur.122</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dichter</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Richey</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rittenberg</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sabatino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bodfish</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Reward circuitry function in autism during face anticipation and outcomes</article-title>
<source/>J. Autism Dev. Disord.
          <year>2012</year>
<volume>42</volume>
<fpage>147</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-011-1221-1</pub-id>
<pub-id pub-id-type="pmid">22187105</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohls</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reward system dysfunction in autism spectrum disorders</article-title>
<source/>Soc. Cogn. Affect. Neurosci.
          <year>2013</year>
<volume>8</volume>
<fpage>565</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1093/scan/nss033</pub-id>
<pub-id pub-id-type="pmid">22419119</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delmonte</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social and monetary reward processing in autism spectrum disorders</article-title>
<source/>Mol. Autism
          <year>2012</year>
<volume>3</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-7</pub-id>
<pub-id pub-id-type="pmid">23014171</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>L M</given-names>
</name>
<name>
<surname>Krasileva</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>S A</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>L E</given-names>
</name>
<name>
<surname>Ponting</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McCarron</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>J K</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D H</given-names>
</name>
<name>
<surname>Bookheimer</surname>
<given-names>S Y</given-names>
</name>
<name>
<surname>Dapretto</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Additive effects of oxytocin receptor gene polymorphisms on reward circuitry in youth with autism</article-title>
<source/>Molecular Psychiatry
          <year>2016</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1134</fpage>
<lpage>1139</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.209</pub-id>
<pub-id pub-id-type="pmid">27843152</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<mixed-citation publication-type="other">American Psychological Assocaition. <italic>Diagnostic and statistical manual of mental disorders.</italic> 5th edn. (American Psychological Assocaition, 2013).</mixed-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<mixed-citation publication-type="other">Lord, C. et al. <italic>Autism Diagnostic Observation Schedule</italic> 2nd edn. (Western Psychological Services, Torrance, 2012).</mixed-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders</article-title>
<source/>J. Autism Dev. Disord.
          <year>1994</year>
<volume>24</volume>
<fpage>659</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1007/BF02172145</pub-id>
<pub-id pub-id-type="pmid">7814313</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<mixed-citation publication-type="other">Beran, T. N. Elliott, C. D. (2007). Differential Ability Scales (2nd ed.). <italic>Can. J. Sch. Psychol</italic>. <bold>22</bold>, 128–132 (Harcourt Assessment, San Antonio, TX, 2007).</mixed-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<mixed-citation publication-type="other">Wechsler, D. <italic>The Wechsler Intelligence Scale For Children</italic>. (Psychological Corporation, New York, NY, 1991).</mixed-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<mixed-citation publication-type="other">Wechsler, D. <italic>Wechsler Abbreviated Scale of Intelligence</italic>. (NCS Pearson, San Antonio, TX, 1999).</mixed-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<mixed-citation publication-type="other">Constantino, J. &amp; Gruber, C. <italic>Social Responsiveness Scale (SRS) Manual</italic>. (Western Psychological Services, Los Angeles, 2005).</mixed-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Advances in functional and structural MR image analysis and implementation as FSL</article-title>
<source/>Neuroimage
          <year>2004</year>
<volume>23</volume>
<fpage>S208</fpage>
<lpage>S219</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.07.051</pub-id>
<pub-id pub-id-type="pmid">15501092</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</article-title>
<source/>Comput. Biomed. Res.
          <year>1996</year>
<volume>29</volume>
<fpage>162</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1006/cbmr.1996.0014</pub-id>
<pub-id pub-id-type="pmid">8812068</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bannister</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</article-title>
<source/>Neuroimage
          <year>2002</year>
<volume>17</volume>
<fpage>825</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1006/nimg.2002.1132</pub-id>
<pub-id pub-id-type="pmid">12377157</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Power</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>AZ</given-names>
</name>
<name>
<surname>Schlaggar</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion</article-title>
<source/>Neuroimage
          <year>2012</year>
<volume>59</volume>
<fpage>2142</fpage>
<lpage>2154</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.10.018</pub-id>
<pub-id pub-id-type="pmid">22019881</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faul</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erdfelder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Buchner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>A-G</given-names>
</name>
</person-group>
<article-title>Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses</article-title>
<source/>Behav. Res. Methods
          <year>2009</year>
<volume>41</volume>
<fpage>1149</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="doi">10.3758/BRM.41.4.1149</pub-id>
<pub-id pub-id-type="pmid">19897823</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skuse</surname>
<given-names>DH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social communication competence and functional adaptation in a general population of children: preliminary evidence for sex-by-verbal IQ differential risk</article-title>
<source/>J. Am. Acad. Child Adolesc. Psychiatry
          <year>2009</year>
<volume>48</volume>
<fpage>128</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1097/CHI.0b013e31819176b8</pub-id>
<pub-id pub-id-type="pmid">19106766</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M-C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A behavioral comparison of male and female adults with high functioning autism spectrum conditions</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e20835</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0020835</pub-id>
<pub-id pub-id-type="pmid">21695147</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandy</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex differences in autism spectrum disorder: evidence from a large sample of children and adolescents</article-title>
<source/>J. Autism Dev. Disord.
          <year>2012</year>
<volume>42</volume>
<fpage>1304</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-011-1356-0</pub-id>
<pub-id pub-id-type="pmid">21947663</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halladay</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>36</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0019-y</pub-id>
<pub-id pub-id-type="pmid">26075049</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wichmann</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Changing views of basal ganglia circuits and circuit disorders</article-title>
<source/>Clin. EEG Neurosci.
          <year>2010</year>
<volume>41</volume>
<fpage>61</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1177/155005941004100204</pub-id>
<pub-id pub-id-type="pmid">20521487</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>DeLong</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Strick</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Parallel organization of functionally segregated circuits linking basal ganglia and cortex</article-title>
<source/>Annu. Rev. Neurosci.
          <year>1986</year>
<volume>9</volume>
<fpage>357</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ne.09.030186.002041</pub-id>
<pub-id pub-id-type="pmid">3085570</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex differences in repetitive stereotyped behaviors in autism: Implications for genetic liability</article-title>
<source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
          <year>2012</year>
<volume>159B</volume>
<fpage>5</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.31238</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans</article-title>
<source/>Brain Imaging Behav.
          <year>2015</year>
<volume>9</volume>
<fpage>754</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1007/s11682-014-9333-9</pub-id>
<pub-id pub-id-type="pmid">25416642</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans</article-title>
<source/>Genes. Brain. Behav.
          <year>2015</year>
<volume>14</volume>
<fpage>516</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1111/gbb.12234</pub-id>
<pub-id pub-id-type="pmid">26178189</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waller</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An oxytocin receptor polymorphism predicts amygdala reactivity and antisocial behavior in men</article-title>
<source/>Soc. Cogn. Affect. Neurosci.
          <year>2016</year>
<volume>11</volume>
<fpage>1218</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="doi">10.1093/scan/nsw042</pub-id>
<pub-id pub-id-type="pmid">27036876</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Aron</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Poldrack</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Ventral–striatal/nucleus–accumbens sensitivity to prediction errors during classification learning</article-title>
<source/>Hum. Brain Mapp.
          <year>2006</year>
<volume>27</volume>
<fpage>306</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.20186</pub-id>
<pub-id pub-id-type="pmid">16092133</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montague</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Dayan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sejnowski</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>A framework for mesencephalic dopamine systems based on predictive Hebbian learning</article-title>
<source/>J. Neurosci.
          <year>1996</year>
<volume>16</volume>
<fpage>1936</fpage>
<lpage>1947</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-05-01936.1996</pub-id>
<pub-id pub-id-type="pmid">8774460</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsgodt</surname>
<given-names>KH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The accumbofrontal tract: diffusion tensor imaging characterization and developmental change from childhood to adulthood</article-title>
<source/>Hum. Brain Mapp.
          <year>2015</year>
<volume>36</volume>
<fpage>4954</fpage>
<lpage>4963</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.22989</pub-id>
<pub-id pub-id-type="pmid">26366528</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>